The metabolic syndrome and chronic kidney disease in a Southeast Asian cohort

Kitiyakara, C.; Yamwong, S.; Cheepudomwit, S.; Domrongkitchaiporn, S.; Unkurapinun, N.; Pakpeankitvatana, V.; Sritara, P.
April 2007
Kidney International;Apr2007, Vol. 71 Issue 7, p693
Academic Journal
US adults with metabolic syndrome, as defined by National Cholesterol Education Program Adult Treatment Panel III (NCEP ATP III) criteria, have been shown to be at increased risk of chronic kidney disease (CKD), but there is limited information in other populations. The relationship between metabolic syndrome and CKD (defined as estimated glomerular filtration rate <60 ml/min/1.73 m2) was examined in a Southeast Asian cohort. This relationship was examined when the subjects (n=3195) were initially recruited in a cross-sectional analysis. The risks of developing new CKD associated with metabolic syndrome were also examined prospectively in a subgroup (n=2067) without CKD at entry after 12 years follow-up. Metabolic syndrome was defined according to both NCEP ATP III and the new International Diabetes Federation (IDF) criteria. The prevalence of CKD was 1.6%, and the incidence of new CKD was 6.3%. Metabolic syndrome by NCEP ATP III definition was associated with the increased risk of CKD at baseline (adjusted odds ratio (OR) 2.48 and 95% confidence interval 1.33–4.62), and of developing new CKD at follow-up (adjusted OR 1.62 and 95% confidence interval 1.00–2.61). There was a significant graded relationship between the number of metabolic syndrome components present and risk of CKD. By contrast, metabolic syndrome by IDF definition was not associated with increased risk of CKD. These results suggest the relationship between CKD and metabolic syndrome in a Southeast Asian population is highly dependent on the criteria used to define metabolic syndrome.Kidney International (2007) 71, 693–700. doi:10.1038/sj.ki.5002128; published online 7 February 2007


Related Articles

  • Diabetes therapy could increase the risk of MetS.  // GP: General Practitioner;3/23/2007, p4 

    The article reports that intensive treatment of type-1 diabetes could increase the risk of a patient developing metabolic syndrome. The findings are from a sub-study of the Diabetes Control and Complications trial. Type-1 diabetes patients were assigned to either intensive or conventional...

  • In This Issue.  // Kidney International;Dec2007, Vol. 72 Issue 11, p1297 

    The article presents abstracts on medical topics which include "CKD and cannabinoid antagonists in obese animals," "VEGF receptor blockade in PKD," and "Thiazolidinediones in albuminuria of diabetes."

  • Research in HIV-related renal diseases lags behind their burden to the ‘positive’ community. Szczech, L. A. // Kidney International;Dec2007, Vol. 72 Issue 11, p1303 

    Although outcomes for persons with HIV infection and renal disease have improved, the analysis by Choi et al. suggests that they remain similar to or worse than outcomes for persons with diabetes mellitus. This study should be used to frame the research resources that we devote to furthering...

  • Complete protection from gentamicin-induced acute renal failure in the diabetes mellitus rat. Teixeira, Ruth Bier; Kelley, Jan; Alpert, Helen; Pardo, Victoriano; Vaamonde, Carlos A. // Kidney International;Apr1982, Vol. 21 Issue 4, p600 

    The possible protective effect of solute and water diuresis on the development of acute renal failure (ARF) following administration of gentamicin, 40 mg/kg of body wt per day for 14 days, was studied in unanesthetized rats. Adult female Sprague-Dawley rats with streptozotocin-induced diabetes...

  • Magnitude of end-stage renal disease in IDDM: A 35 year follow-up study. Krolewski, Martin; Eggers, Paul W.; Warram, James H. // Kidney International;Dec1996, Vol. 50 Issue 6, p2041 

    Significant improvements were made during the last two decades in the treatment of IDDM patients. To assess the risk of ESRD in a population that was exposed to these improvements, we determined the cumulative incidence of ESRD in a cohort of 142 white patients who were aged less than 21 years...

  • Clinical spectrum associated with recurrent genomic rearrangements in chromosome 17q12. Nagamani, Sandesh Chakravarthy Sreenath; Erez, Ayelet; Shen, Joseph; Chumei Li; Roeder, Elizabeth; Cox, Sarah; Karaviti, Lefkothea; Pearson, Margret; Kang, Sung-Hae L.; Sahoo, Trilochan; Lalani, Seema R.; Stankiewicz, Pawel; Sutton, V. Reid; Sau Wai Cheung // European Journal of Human Genetics;Mar2010, Vol. 18 Issue 3, p278 

    Deletions in chromosome 17q12 encompassing the HNF1β gene cause cystic renal disease and maturity onset diabetes of the young, and have been recently described as the first recurrent genomic deletion leading to diabetes. Earlier reports of patients with this microdeletion syndrome have...

  • Metabolic Syndrome Raises CKD Risk.  // Renal & Urology News;Nov2012, Vol. 11 Issue 11, p26 

    The article presents information on the findings of a study according to which metabolic syndrome increases the risk for chronic kidney disease (CKD).

  • Treatment of Metabolic Syndrome Slows Progression of Diabetic Nephropathy. Duran-Perez, Edgar G.; Almeda-Valdes, Paloma; Cuevas-Ramos, Daniel; Campos-Barrera, Eugenia; Muñoz-Hernandez, Liliana; Gomez-Perez, Francisco J. // Metabolic Syndrome & Related Disorders;Dec2011, Vol. 9 Issue 6, p483 

    Background: Metabolic syndrome contributes to the development of albuminuria and to the decrease of glomerular filtration rate (GFR) in type 2 diabetes patients. The aim of this study was to analyze the effect of MS treatment on the progression of diabetic nephropathy (DN). Methods: This was a...

  • Comparison of Anthropometric Indices in Predicting Metabolic Syndrome Components in Children. Agirbasli, Mehmet; Agaoglu, Nihat Bugra; Ergonul, Onder; Yagmur, Ibrahim; Aydogar, Hakan; Oneri, Temel; Ozturk, Osman // Metabolic Syndrome & Related Disorders;Dec2011, Vol. 9 Issue 6, p453 

    Background: The International Diabetes Federation (IDF) defines metabolic syndrome among children. In addition to the abdominal obesity (waist circumference ≥90 percentile of locally representative sample), the risk criteria for metabolic syndrome includes elevated blood pressure,...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics